Product Description
Product introduction
Bilypsa Tablet is a medicine used in the treatment of Noncirrhotic Non-Alcoholic Steatohepatitis, Non-alcoholic Fatty Liver Disease (NAFLD) with comorbidities (like obesity, Type 2 Diabetes Mellitus, Dyslipidemia or Metabolic Syndrome), and high cholesterol in diabetes (diabetic dyslipidemia).
Bilypsa Tablet may be taken with or without food, at the same time each day, to get the most benefit and you should not stop taking it unless your doctor recommends it. It is important to stay on the diet and exercise program recommended by your doctor while taking this medicine. Your lifestyle plays a big part in maintaining a healthy body weight, which will help protect your liver to a great extent.
The most common side effects of this medicine are flatulence, indigestion, abdominal distension, increased body temperature, and weakness. These are usually not severe. Please consult your doctor if the side effects worry you or if they do not go away.
Before taking this medicine, let your doctor know if you have ever had kidney disease, heart or pancreas problems, or if you drink a lot of alcohol. Pregnant or breastfeeding women should also consult their doctor before taking it. Some other medicines you are taking may interfere with it so make sure your doctor knows about all the other medicines you are using. Limit your alcohol intake while taking this medicine because it can degrade your liver health. You may need regular tests such as liver function test, kidney function and blood glucose levels to check that the medicine is working properly.
How Does Bilypsa Work?Bilypsa contains Saroglitazar, which targets lipid and glucose metabolism to lower elevated blood triglyceride and cholesterol levels, while also improving glycemic control. It is specifically designed for patients with type 2 diabetes mellitus and associated dyslipidemia.
Usage Instructions and DosageThese tablets are meant to be taken orally, either with or without food, following your physician's dosage recommendations. Always adhere to prescribed instructions and do not discontinue the medicine without medical advice, to ensure optimal benefits and minimize potential side effects.
Storage and Shelf LifeTo maintain effectiveness, store Bilypsa tablets in a cool, dry place away from direct sunlight. Each strip contains 10 tablets and the product should not be used beyond its 2-year expiry period from the manufacturing date.
FAQ's of Bilypsa saroglitazar tablets:
Q: What condition is Bilypsa (Saroglitazar) prescribed for?
A: Bilypsa is prescribed to treat high cholesterol and triglyceride levels, diabetic dyslipidemia, and type 2 diabetes mellitus in adults.
Q: How should I take Bilypsa tablets for best results?
A: It should be taken orally, with or without food, exactly as prescribed by your doctor. Do not alter the dosage or stop taking the tablets without consulting your physician.
Q: What are the possible side effects of Bilypsa?
A: Some individuals may experience nausea, vomiting, abdominal pain, or mild gastrointestinal disturbances. If these symptoms become persistent or severe, contact your healthcare provider.
Q: When can I expect to see improvements after starting Bilypsa?
A: Changes in lipid and glucose levels may be observed after several weeks of regular use, but the timeline varies by individual. Follow-up lab tests and doctor's consultations are essential for monitoring progress.
Q: Where should Bilypsa be stored to ensure its potency?
A: Store the tablets in a cool, dry place, away from direct sunlight and moisture, as instructed on the packaging.
Q: What is the expiry period for Bilypsa tablets?
A: Bilypsa tablets have a shelf life of 2 years from the date of manufacturing. Always check the expiry date on the strip before use.
Q: What benefits does Bilypsa provide for patients with type 2 diabetes and dyslipidemia?
A: Bilypsa not only lowers triglycerides and cholesterol but also helps regulate blood sugar, offering a comprehensive approach to managing both lipid and glucose abnormalities in type 2 diabetes patients.